Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta del Mar (33)

2024

  1. Coronary Flow Reserve and Myocardial Resistance Reserve Changes After Transcatheter Aortic Valve Implantation in Aortic Stenosis

    American Journal of Cardiology, Vol. 214, pp. 109-114

2023

  1. Role of microRNAs in arrhythmogenic cardiomyopathy: translation as biomarkers into clinical practice

    Translational Research, Vol. 259, pp. 72-82

  2. Value of NT-proBNP and Galectin-3 as Biomarkers in the Follow-Up of Asymptomatic Elderly Patients with Severe Aortic Stenosis

    Journal of Clinical Medicine, Vol. 12, Núm. 8

  3. Volumetric quantification of coronary steal in a giant coronary fistula

    Revista Espanola de Cardiologia, Vol. 76, Núm. 8, pp. 664

2022

  1. A microRNA Signature for the Diagnosis of Statins Intolerance

    International Journal of Molecular Sciences, Vol. 23, Núm. 15

  2. Early recruitable coronary collaterals preserve miocardial viability in late presentation infarctions

    Coronary Artery Disease, Vol. 33, Núm. 6, pp. 433-439

  3. The Role of MicroRNAs in Dilated Cardiomyopathy: New Insights for an Old Entity

    International Journal of Molecular Sciences, Vol. 23, Núm. 21

  4. miR-16-5p Suppression Protects Human Cardiomyocytes against Endoplasmic Reticulum and Oxidative Stress-Induced Injury

    International Journal of Molecular Sciences, Vol. 23, Núm. 3

2021

  1. Circulating circRNA as biomarkers for dilated cardiomyopathy etiology

    Journal of Molecular Medicine, Vol. 99, Núm. 12, pp. 1711-1725

  2. Elderly population with COVID-19 and the accuracy of clinical scales and d-dimer for pulmonary embolism: The OCTA-COVID study

    Journal of Clinical Medicine, Vol. 10, Núm. 22

  3. Electrocardiographic findings in true acute left main coronary total occlusion a subanalisys from ATOLMA registry

    Journal of Electrocardiology, Vol. 68, pp. 48-52

  4. Ischemic dilated cardiomyopathy pathophysiology through microRNA-16-5p

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 740-749

  5. Personalized genetic diagnosis of congenital heart defects in newborns

    Journal of Personalized Medicine, Vol. 11, Núm. 6

  6. Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy

    Scientific Reports, Vol. 11, Núm. 1

  7. Predictive factors of pulmonary embolism in older patients with sars-cov-2: The octa-covid-19 study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

2020

  1. Emerging role of microRNAs in dilated cardiomyopathy: evidence regarding etiology

    Translational Research, Vol. 215, pp. 86-101

  2. Peripheral microRNA panels to guide the diagnosis of familial cardiomyopathy

    Translational Research, Vol. 218, pp. 1-15

2019

  1. Differential expression of circulating miRNAs as a novel tool to assess BAG3-associated familial dilated cardiomyopathy

    Bioscience Reports, Vol. 39, Núm. 3

2018

  1. Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy

    Journal of Molecular Medicine, Vol. 96, Núm. 8, pp. 845-856

2016

  1. Cardiometabolic risk in patients with chronic renal disease related to hypertriglyceridemia-low HDL -cholesterol association

    Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice